MUBASHIR FAROOQI: Open Payments
NPI 1902858194 · VICTORVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,121 in 61 payments from 8 companies in 2025. Trend: 2023 $746 · 2024 $989 · 2025 $3,121
Food & beverage: $3,121
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $1,443 |
| Teva Pharmaceuticals USA, Inc. | 3 | $383 |
| E.R. Squibb & Sons, L.L.C. | 4 | $327 |
| Axsome Therapeutics, Inc. | 3 | $281 |
| Alkermes, Inc. | 3 | $256 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $256 |
| Otsuka America Pharmaceutical, Inc. | 2 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
Products named: VRAYLAR, COBENFY, REXULTI, Auvelity, LYBALVI, UZEDY, AUSTEDO XR, CAPLYTA.
Industry payments across CA — which companies pay providers there.
